Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8865 |
High Similarity |
NPD1511 |
Approved |
0.8832 |
High Similarity |
NPD1510 |
Phase 2 |
0.8741 |
High Similarity |
NPD1512 |
Approved |
0.8639 |
High Similarity |
NPD1934 |
Approved |
0.8581 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.854 |
High Similarity |
NPD943 |
Approved |
0.8456 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8444 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8406 |
Intermediate Similarity |
NPD1240 |
Approved |
0.838 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.831 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.831 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8255 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8239 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8217 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8134 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8102 |
Intermediate Similarity |
NPD2798 |
Approved |
0.8089 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8056 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8041 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7937 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7935 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7899 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7888 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7888 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7877 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7838 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7832 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7823 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7793 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7744 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7742 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7737 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7736 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7733 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7708 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7702 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7681 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7677 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7651 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7636 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.763 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.761 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7597 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD1933 |
Approved |
0.758 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD228 |
Approved |
0.7556 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7556 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7551 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD919 |
Approved |
0.7533 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7466 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7463 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7451 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7447 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7445 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7432 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7417 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7379 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7379 |
Intermediate Similarity |
NPD411 |
Approved |
0.7379 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7324 |
Intermediate Similarity |
NPD1283 |
Approved |
0.732 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7305 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7305 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7266 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7262 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.726 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7256 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD2354 |
Approved |
0.725 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7244 |
Intermediate Similarity |
NPD920 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1243 |
Approved |
0.723 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7226 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7206 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7164 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7164 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7162 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7153 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7153 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7152 |
Intermediate Similarity |
NPD824 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7113 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7113 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7105 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD17 |
Approved |
0.709 |
Intermediate Similarity |
NPD74 |
Approved |
0.709 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7083 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7071 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7071 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7051 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7018 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7015 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7015 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7014 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD2353 |
Approved |
0.6993 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD7440 |
Discontinued |
0.6981 |
Remote Similarity |
NPD1653 |
Approved |
0.698 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD8313 |
Approved |
0.6977 |
Remote Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD8312 |
Approved |
0.6972 |
Remote Similarity |
NPD4626 |
Approved |
0.6968 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6962
|
Remote Similarity |
NPD5049 |
Phase 3 |